Curaleaf Holdings, Inc.
CURA.TOTSXHealthcare● Active
$16.21
+$1.00(+6.57%)
Market Cap$3.8B
P/E Ratio—
52W High$16.92
52W Low$0.99
Curaleaf Holdings, Inc. (CURA.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CURA.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.29B | $1.34B | $1.35B | $1.34B | $1.21B |
| Cost of Revenue | $0.79B | $0.70B | $0.73B | $0.76B | $0.52B |
| Gross Profit | $0.50B | $0.64B | $0.61B | $0.58B | $0.69B |
| Gross Margin %(computed) | 38.61% | 47.61% | 45.63% | 43.33% | 56.84% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.40B | $0.42B | $0.43B | $0.37B |
| Total Operating Expenses | $0.47B | $0.62B | $0.57B | $0.59B | $0.51B |
| Operating Income | $0.03B | $0.02B | $0.04B | ($0.01B) | $0.18B |
| Operating Margin %(computed) | 2.01% | 1.50% | 3.18% | -0.77% | 14.52% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.10B | $0.10B | $0.10B | $0.09B | $0.08B |
| Income Before Tax | ($0.08B) | ($0.12B) | ($0.12B) | ($0.23B) | $0.06B |
| Income Tax Expense | $0.13B | $0.10B | $0.11B | $0.15B | $0.17B |
| Net Income | ($0.24B) | ($0.22B) | ($0.28B) | ($0.38B) | ($0.11B) |
| Net Margin %(computed) | -18.22% | -16.04% | -20.88% | -28.21% | -9.02% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.93 | $-0.87 | $-0.96 | $-1.59 | $-0.48 |
| Wtd Avg Shares | 0.25B | 0.25B | 0.24B | 0.24B | 0.23B |
| EBITDA | $0.17B | $0.23B | $0.24B | $0.22B | $0.28B |
| EBITDA Margin %(computed) | 13.16% | 17.36% | 17.73% | 16.54% | 23.06% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Curaleaf Holdings, Inc. data
About Curaleaf Holdings, Inc. (CURA.TO) Income Statement
Curaleaf Holdings, Inc. (CURA.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CURA.TO reported revenue of $1.29B, gross profit of $0.50B (gross margin 38.61%), and net income of ($0.24B) — a net profit margin of -18.22%.
Frequently asked questions
CURA.TO · 4 questionsCuraleaf Holdings, Inc. (CURA.TO) reported revenue of $1.29B for 2025, down 3.9% year-over-year.
CURA.TO revenueCURA.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08